Alpha Lipoic Acid Liposomal: What the Label Means and What Proof Would Look Like

Alpha lipoic acid liposomal is a formulation claim, not an evidence claim. It says the alpha-lipoic acid in a product is packaged with phospholipids, fat-like molecules usually taken from soy or sunflower lecithin, meant to form tiny vesicles called liposomes. The word describes how a product is made. It does not show how much alpha-lipoic acid reaches your blood, and it says nothing about effects in the body. Showing an absorption difference takes a study of the finished product in people, compared with a non-liposomal version at the same amount and under the same conditions. None of the six liposomal labels compared below names such a study, and none of the studies cited here tested a liposomal alpha-lipoic acid product in people. FDA’s guidance for liposome drug products describes liposomes as vesicles made of one or more bilayers of molecules such as phospholipids, enclosing a watery core. [1] The Federal Trade Commission (FTC) says health claims need competent and reliable scientific evidence, and gives an absorption claim backed only by animal and laboratory studies as an example of inadequate support. [2]

This page is general education about reading supplement labels. It does not recommend any product or amount, it does not describe health effects of alpha-lipoic acid, and the label records below are examples, not endorsements.

Safety first: if you take insulin or another glucose-lowering medicine, are pregnant or breastfeeding, or are having chemotherapy or radiation therapy, ask your doctor or pharmacist before using any alpha-lipoic acid product, and keep it out of children’s reach. Memorial Sloan Kettering Cancer Center (MSK) warns that alpha-lipoic acid may be harmful for people who take blood-sugar-lowering drugs, lists low blood sugar and nausea among its side effects, and says it may work against chemotherapy and radiation therapy; it also reports that accidental swallowing by children can cause poisoning and convulsions. [3] The NIH Office of Dietary Supplements (ODS) says supplements can interact with some medicines and that many have not been well tested for safety in children or in women who are pregnant or nursing. [4]

Use the ingredient-label checklist

What liposomal means on a label

A liposome is a structure, not an ingredient. In FDA’s description, liposomes are formed by molecules such as phospholipids that arrange into one or more double layers around a watery compartment; water-soluble substances usually sit in that core and fat-soluble ones in the layers. [1] FDA separates liposomes from other lipid formulations: a liposome product is different from an emulsion, and a drug-lipid complex is made by mixing a drug with lipids “in such a way that liposomes are not created.” [1] That guidance was written for drug applications, not supplements, and it does not mention alpha-lipoic acid, but it is the clearest federal description of what the word means.

The label lists ingredients, not structure. A Supplement Facts panel can show a phospholipid such as phosphatidylcholine, or lecithin among the other ingredients, but it cannot show whether liposomes actually formed, how large they are, or how much of the alpha-lipoic acid is inside them. FDA’s guidance lists those as measured quality attributes: particle size and size distribution, encapsulation efficiency (the amount inside the liposomes compared with the total), and leakage during storage. [1] None of the six records below gives any of these. [5] [6] [7] [8] [9] [10]

Other words you may see. One label uses “Pro-liposomal,” which its record lists as a trademark statement; the term is not defined in FDA’s guidance. [8] [1] Another lists a “Phospholipid Complex” made with beta-cyclodextrin and sunflower among its other ingredients. [10] Because FDA describes complexes and liposomes as different structures, a label that uses both words leaves the structure unclear; ask the manufacturer which it is. [1]

The lipoic acid itself comes in more than one form. Alpha-lipoic acid has two mirror-image forms, R and S. Researchers describe R-lipoic acid as the natural form, the racemic mixture as a combination of both forms, and sodium R-lipoate as a salt of the R form; they note that R-lipoic acid tends to polymerize and dissolves poorly in water. [11] A label that says only “alpha lipoic acid” does not say which form it contains. For practice reading ingredient lists and panels, see the food label reading worksheet.

What it takes to show an absorption difference

Absorption and bioavailability are measured, not described. Federal drug rules define bioavailability as “the rate and extent to which the active ingredient or active moiety is absorbed from a drug product and becomes available at the site of drug action.” [12] Those rules apply to drugs; supplements do not have to show bioavailability, and ODS notes that supplements do not need FDA approval before they are sold. [4] They still describe what a fair absorption comparison involves.

The elements of a fair comparison. Drawing on FDA’s drug study rules, its liposome guidance and FTC’s substantiation guidance, a study that could support a liposomal absorption difference would have these features: [13] [1] [2]

• The finished product as sold. FTC asks whether the dosage and formulation of the advertised product match the product used in the study, and whether it is taken the same way. [2]
• A non-liposomal comparison with the same ingredient. FDA’s guidance calls for comparing liposome and nonliposome products that have the same active ingredient and are given the same way, and drug studies compare a product with an appropriate reference. [1] [13] For alpha-lipoic acid, that means the same form, R or racemic, at the same amount.
• People, not animals or laboratory models. FTC says animal and laboratory studies may provide background but are not sufficient on their own to support health-related claims. [2]
• A controlled design. FDA describes single-dose studies using a crossover or parallel design, and drug bioavailability studies are generally done in healthy adults under standardized conditions. [1] [13]
• Blood levels measured over time with validated methods, separating what is still inside the liposomes from what has been released. [1]
• Each ingredient, for a combination product. In drug rules, a combination product is compared with each active ingredient given in separate single-ingredient preparations. [13] FTC also asks whether the ingredient or combination in the advertised product is the same as in the study. [2]

Even a well-run comparison would show only blood levels. A difference in blood levels is not evidence of any health effect, and FDA’s liposome guidance says it does not cover clinical efficacy and safety studies. [1]

What published studies show, and what they do not

The dosage form can change blood levels. In a crossover study, 24 healthy adults took single 600 mg doses of racemic alpha-lipoic acid as three different tablets and as an oral solution, fasting, with blood samples over 8 hours. For the R form, the tablets reached 36% to 43% of the solution’s peak level and 64% to 79% of its total exposure. [14] Two of the authors were affiliated with a drug company, and no liposome was tested. The point for label readers is that a result for one form of alpha-lipoic acid does not carry over to another.

Absorbed is not the same as available. A pharmacology study describes oral racemic alpha-lipoic acid as readily and nearly completely absorbed, yet with an absolute bioavailability of about 30%, because the liver takes up much of it. [15] A label statement about absorption does not tell you which of these it means.

Other formulations have been compared in very small studies. In six healthy volunteers, R-lipoic acid bound to gamma-cyclodextrin, a ring-shaped sugar molecule, produced total exposure 2.5 times that of R-lipoic acid on its own. [16] That was a cyclodextrin complex, not a liposome, and several authors were affiliated with a company.

The liposomal research found here was in rats. Researchers made their own liposomal R-lipoic acid, with particles of about 150 nm, and reported that it kept R-lipoic acid from breaking down under acidic laboratory conditions (pH 1.2). In rats given 10 mg of R-lipoic acid per kilogram of body weight, the authors report that blood exposure to R-lipoic acid and to its reduced form increased 2.8-fold and 5.8-fold. [17] Some co-authors were from a company. The study tested no product sold under the labels on this page, and no people.

The gap. None of the studies cited here tested a liposomal alpha-lipoic acid product in people. FTC’s guidance describes a supplement company that relied on animal and laboratory studies to claim its vitamin reached the bloodstream more easily than other forms; FTC called that support inadequate, in part because human research was feasible and is the type of research experts generally consider necessary. [2]

Six liposomal alpha-lipoic acid labels compared

Method. The table compares six supplements sold as liposomal that list alpha-lipoic acid, as recorded in the NIH Dietary Supplement Label Database (DSLD), which captures the information printed on supplement labels sold in the United States, including products no longer sold. [18] All six records are marked as on the market; they were entered between 2021 and 2024. Three are liquids and three are capsules. They are every on-market record found in which the product is described as liposomal and lists alpha-lipoic acid; records whose liposomal wording referred to a different ingredient were left out. They are not a ranking, and each is identified by its DSLD record number only. DSLD records are label text, not test results. Amounts are per serving as the Supplement Facts panel lists them, and delivery or absorption statements are noted but not repeated.

Every label is a combination. All six list alpha-lipoic acid alongside other dietary ingredients, from one (labels A, B and D) to nine (label F). [5] [6] [8] [10] A study of alpha-lipoic acid on its own would not describe any of these products, and FTC asks whether the combination of ingredients in a product is the same as in the study. [2]

The form is not always named. Labels A and B list the R form as a sodium salt, and labels C and D name R-alpha lipoic acid; labels E and F do not say whether theirs is the R form or the racemic mixture. [5] [6] [7] [8] [9] [10] Amounts listed range from 20 mg to 200 mg per serving.

The phospholipid source varies. Three labels list soy lecithin, two list sunflower, and label D names no phospholipid at all, although it is sold as liposomal. [5] [6] [7] [9] [10] [8] Soybeans are a major food allergen, FDA gives “lecithin (soy)” as an example of how a label names an allergen’s source, and the allergen labeling rules cover dietary supplements. [19] [20]

Some amounts need a question. Label A lists 20 mg of lipoic acid from sodium R-lipoate, while label B lists 33 mg of “Na-R-Lipoic Acid” without saying whether that is the weight of the salt or of the lipoic acid in it. [5] [6] Label E’s record gives the unit as “mg α-TE” rather than plain milligrams. [9] For either, ask the manufacturer.

Statements are not studies. Five of the six labels carry a statement about delivery, absorption or the bloodstream; one refers to clinical proof but, like the others, names no study. [8] Structure/function claims are not approved by FDA before sale, though the manufacturer must have substantiation that a claim is truthful and not misleading. [21]

Ingredient-label checklist for liposomal alpha-lipoic acid

Use these steps with each package in front of you, and write down the date you checked.

• Find the form. Look for R-lipoic acid, sodium R-lipoate or plain alpha-lipoic acid; plain wording does not say whether the product is the R form or the racemic mixture. [11] [10]
• Find the amount and unit per serving. For a salt such as sodium R-lipoate, ask whether the number is the weight of the salt or of the lipoic acid. [6]
• Find the phospholipid. Look for phosphatidylcholine or lecithin and its source; if no phospholipid is listed, ask what makes the product liposomal. [8] [1]
• Check for soy if you are allergic. Soy lecithin is a common phospholipid source, and soy can be named in the Supplement Facts panel or the ingredient list. [19] [20]
• Count the other ingredients. A study of alpha-lipoic acid alone does not describe a combination product. [2] [13]
• Read delivery wording as the manufacturer’s statement. It is not a test result, and FDA does not approve it before sale. [21]
• Ask for the study behind any absorption statement. Check that it tested the finished product, in people, against a non-liposomal version with the same form and amount, under the same conditions, with blood levels measured over time. [1] [2]
• Ask how the liposomes were measured. Particle size, the share of alpha-lipoic acid inside the liposomes and stability during storage are the attributes FDA’s guidance lists. [1]
• Set aside animal and laboratory results. They may give background but do not on their own support a claim about people. [2]
• Bring medicine and pregnancy questions to your pharmacist. Mention every supplement and medicine you take, especially glucose-lowering medicines, chemotherapy or radiation therapy, and whether you are pregnant or breastfeeding. [3] [4]
• Match the record to your package. DSLD includes labels for products no longer sold, and labels change. [18]

Safety notes

• MSK says alpha-lipoic acid may be harmful for people who take blood-sugar-lowering drugs, and lists nausea and low blood sugar among its side effects. [3]
• MSK reports insulin autoimmune syndrome, an immune reaction that can cause low blood sugar, in genetically predisposed people who took alpha-lipoic acid. [3]
• MSK says alpha-lipoic acid may work against chemotherapy and radiation therapy, and that accidental swallowing by children can cause poisoning and convulsions. [3]
• ODS asks readers to tell their health care providers, including pharmacists, about any supplements they take. [4]

Where to go next

More label guides are listed under Ingredients and labels. For how a supplement label shows the source of each vitamin, see the guide to a plant based vitamin b complex.

Common questions

What does liposomal alpha lipoic acid mean?

It means the manufacturer says the alpha-lipoic acid is combined with phospholipids intended to form liposomes, small vesicles with lipid layers around a watery core. The label does not show whether liposomes formed or how much of the ingredient is inside them. [1]

What evidence would show a liposomal absorption difference?

A controlled study in people of the finished product, compared with a non-liposomal version of the same form at the same amount, measuring blood levels over time. Animal and laboratory studies alone are not enough, and the liposomal research cited here was in rats. [2] [1] [17]

What is the difference between R-lipoic acid and alpha-lipoic acid?

R-lipoic acid is one of the two mirror-image forms of alpha-lipoic acid; the racemic mixture contains both forms. A label that says only “alpha lipoic acid” does not say which form it holds. [11]

What does pro-liposomal mean?

It is a term on one label, listed in its record as a trademark statement, and it is not defined in FDA’s liposome guidance. Ask the manufacturer what structure it describes and how it was measured. [8] [1]

Does a liposomal supplement go through the same review as a liposomal drug?

No. FDA’s liposome guidance is written for drug applications; supplements do not need FDA approval before they are sold. [1] [4]

Does liposomal mean the product contains soy?

Not always. Among the six labels above, three list soy lecithin, two list sunflower and one names no phospholipid. Soy must be identified on the label when present. [7] [9] [20]

Can I take alpha-lipoic acid with diabetes medicine?

Ask your doctor or pharmacist first. MSK warns that alpha-lipoic acid may be harmful for people who take blood-sugar-lowering drugs. [3]

If you take insulin or another glucose-lowering medicine, are pregnant or breastfeeding, or are having chemotherapy or radiation therapy, ask your doctor or pharmacist before using any alpha-lipoic acid product, and keep it out of children’s reach. [3] [4]

Use the ingredient-label checklist

Sources and limitations

1. U.S. Food and Drug Administration: Liposome Drug Products: Chemistry, Manufacturing, and Controls; Human Pharmacokinetics and Bioavailability; and Labeling Documentation. Guidance for Industry. April 2018. Nonbinding guidance for drug applications; it sets no rules for supplements and does not mention alpha-lipoic acid.
2. Federal Trade Commission: Health Products Compliance Guidance. December 2022. Guidance for advertisers on substantiation; it does not evaluate any alpha-lipoic acid product.
3. Memorial Sloan Kettering Cancer Center, About Herbs: Alpha-Lipoic Acid. Last updated July 31, 2026. An herb monograph used here for safety cautions only; several cautions rest on case reports.
4. NIH Office of Dietary Supplements: Dietary Supplements: What You Need to Know. Updated January 4, 2023. General consumer guidance; it does not discuss alpha-lipoic acid or liposomes.
5. NIH Dietary Supplement Label Database: record 248548, liposomal liquid. Entered April 22, 2021. Label text as recorded, not a test of contents; the label in circulation may differ.
6. NIH Dietary Supplement Label Database: record 248527, liposomal liquid. Entered May 22, 2021. Label text as recorded, not a test of contents; the label in circulation may differ.
7. NIH Dietary Supplement Label Database: record 276651, liposomal liquid. Entered November 22, 2022. Label text as recorded, not a test of contents; the label in circulation may differ.
8. NIH Dietary Supplement Label Database: record 291892, liposomal capsule. Entered May 24, 2023. Label text as recorded, not a test of contents; the label in circulation may differ.
9. NIH Dietary Supplement Label Database: record 298390, liposomal capsule. Entered October 24, 2023. Label text as recorded, not a test of contents; the label in circulation may differ.
10. NIH Dietary Supplement Label Database: record 305956, liposomal capsule. Entered January 24, 2024. Label text as recorded, not a test of contents; the label in circulation may differ.
11. Carlson and colleagues. The plasma pharmacokinetics of R-(+)-lipoic acid administered as sodium R-(+)-lipoate to healthy human subjects. Alternative Medicine Review. 2007 (PubMed abstract). A small study by authors from a company that supplies R-lipoic acid; cited here only for the names of the forms.
12. Electronic Code of Federal Regulations: 21 CFR 314.3, Definitions. eCFR text, Title 21 up to date as of October 13, 2026. A drug-regulation definition; supplements are not required to show bioavailability.
13. Electronic Code of Federal Regulations: 21 CFR 320.25, Guidelines for the conduct of an in vivo bioavailability study. eCFR text, Title 21 up to date as of October 13, 2026. Rules for drug studies, cited only to show what a formal comparison involves.
14. Hermann and colleagues. Enantiomer-selective pharmacokinetics, oral bioavailability, and sex effects of various alpha-lipoic acid dosage forms. Clinical Pharmacology: Advances and Applications. 2014 (PubMed abstract). 24 healthy adults; tablets compared with a solution of racemic alpha-lipoic acid. No liposome was tested, and two authors were affiliated with a drug company.
15. Teichert and colleagues. Plasma kinetics, metabolism, and urinary excretion of alpha-lipoic acid following oral administration in healthy volunteers. Journal of Clinical Pharmacology. 2003 (PubMed abstract). The bioavailability figure is the authors’ summary for oral racemic alpha-lipoic acid; it says nothing about liposomes.
16. Ikuta and colleagues. Bioavailability of an R-α-lipoic acid/γ-cyclodextrin complex in healthy volunteers. International Journal of Molecular Sciences. 2016 (PubMed abstract). Six people and a cyclodextrin complex, not a liposome; several authors were affiliated with a company.
17. Halder and colleagues. Strategic application of liposomal system to R-α-lipoic acid for the improvement of nutraceutical properties. Drug Development and Industrial Pharmacy. 2022 (PubMed abstract). A rat and laboratory study of the authors’ own liposome, with co-authors from a company; no people and no product on this page were tested.
18. NIH Office of Dietary Supplements: Dietary Supplement Label Database, About. Records what labels say; it does not test products, and it includes off-market labels.
19. U.S. Food and Drug Administration: Food Allergies: What You Need to Know. Content current as of August 16, 2024. Consumer guidance on allergen labeling; it does not evaluate any product.
20. U.S. Food and Drug Administration: Questions and Answers Regarding Food Allergens, Including the Food Allergen Labeling Requirements of the Federal Food, Drug, and Cosmetic Act (Edition 5): Guidance for Industry. January 2025. Nonbinding guidance for manufacturers; it describes labeling rules, including for supplements, and does not verify any product.
21. U.S. Food and Drug Administration: Structure/Function Claims. Content current as of March 28, 2024. Explains claim rules; FDA does not review each label statement before sale.